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Vertebrate vision starts with light absorption by visual pigments in rod and cone photoreceptor 
cells of the retina. Rhodopsin, in rod cells, responds to dim light, whereas three types of cone 
opsins (red, green, and blue) function under bright light and mediate color vision. Cone opsins 
regenerate with retinal much faster than rhodopsin, but the molecular mechanism of regeneration 
is still unclear. Recent advances in the area pinpoint transient intermediate opsin conformations, 
and a possible secondary retinal binding site, as determinant factors for regeneration. In this 
article, we compile previous and recent findings to discuss possible mechanisms of ligand entry 
in cone opsins, involving a secondary binding site, which may have relevant functional and 




































































Vision, Rhodopsin, and Cone Opsins 
The first step in human visual perception involves photon absorption by four different visual 
pigments. These visual pigments (see Glossary) include an apoprotein, opsin, covalently bound 
to the chromophore 11-cis-retinal (11CR), a vitamin-A derivative that functions as an inverse 
agonist locking the photoreceptor opsin protein in its inactive state. This inactive conformation 
corresponds to the resting state of these retinal photoreceptor proteins that serves as a firstline 
molecule for visual perception which is readily available for photon absorption [1]. Upon 
illumination, 11CR undergoes a cis-to-trans isomerization to produce all-trans-retinal (ATR), a 
reaction that displaces the β-ionone ring moiety from the canonical chromophore binding site 
(Fig. 1A). This photochemical change is the first event in vision and triggers concerted 
conformational changes on the receptor that lead to its active state which, in turn, initiates 
subsequent signaling pathways [2]. Rhodopsin is the photoreceptor protein localized in rod cells 
of the retina, where it is widely distributed, and mediates scotopic vision at low light intensities. 
Cone opsins are found in cone photoreceptor cells, mainly in the fovea region of the retina, and 
mediate color perception under bright light illumination conditions. Vertebrates with color vision 
have different types of cone pigments in the retina which evolved from a common non-visual 
opsin ancestor. They are classified into four gene families, namely L (red), S (purple-UV), M1 
(blue), and M2 (green) [3, 4]. Phylogenetic studies have shown that rhodopsin diverged later 
from the M2 group (see Fig. 2A).  
Cone visual pigments evolved to account for the precise spectral tuning of different 
wavelengths of visible light [5]. At the molecular level, this was achieved by selecting distinct 
amino acids at the canonical binding pocket for the 11CR ligand. (Fig. 2B). Humans and closely 
related primates procured trichromatic color vision, which involves red-, green-, and blue-
sensitive cones [6]. The spectral sensitivity of the visual pigments peaks at approximately 560 
nm (red cone opsin), 530 nm (green cone opsin), 420 nm (blue cone opsin), and 500 nm 
(rhodopsin) [4]. These colors do not always correspond to those of the gene family to which the 
pigment belongs. Thus, while most vertebrate blue pigments belong to M1, human blue opsin is 
part of the S group. Similarly, while most green pigments belong to M2, human green and red 
opsins are part of the L group (see Fig. 2A) [3, 4]. Therefore, the human red and green cone 




































































lower (42% and 44% of red and green cone opsin respectively), and sequence identity between 
cone opsins and rhodopsin ranges between 45 and 48%. 
Opsins belong to the ubiquitous superfamily of G protein-coupled receptors (GPCRs) having the 
characteristic structural (e.g., seven transmembrane helices) and functional (e.g., G-protein 
signaling) features of the family [7]. While no cone opsin structure has yet been solved, several 
rhodopsin structures have already been deposited in the Protein Data Bank (PDB). Rhodopsin 
was not only the first crystal structure of a GPCR to be solved [8], but also the first GPCR 
crystallized in different functional states (i.e., active and inactive conformations) [9, 10]. 
Moreover, rhodopsin has been recently solved in complex with intracellular signaling partners, 
namely the G protein [11] and visual arrestin [12]. All these structures have provided important 
clues for understanding the molecular mechanism of rhodopsin photoactivation and have long 
served as homolog templates to study the structure and activation mechanism of other members 
of the GPCR superfamily, some of whom undoubtedly possess high pharmacologic and 
therapeutic interest [13, 14].  
The nature of rhodopsin function augments this pigment a prominent model for optogenetic 
research and for the progressive development of the optogenetic toolbox with a wide range of 
potential applications [8, 15]. In fact, rhodopsin has been widely studied by biophysical and 
biochemical methods aimed at characterizing the protein photocycle at the molecular level. 
During this cycle (Fig 1B), 11CR isomerization to ATR triggers protein conformational changes 
leading to the Meta I conformation through a series of short-lived photointermediates 
(photorhodopsin, bathorhodopsin, lumirhodopsin). The Meta I intermediate still features the 
chromophore covalently bound to the opsin through a protonated Schiff base (PSB) linkage [16]. 
Subsequent deprotonation of the PSB results in the formation of Meta II with a typical 
absorbance maximum at 380 nm for all opsins. The Meta II state of the photoactivated visual 
pigment binds and activates the G protein, transducin, starting the visual phototransduction 
cascade. This active conformation eventually decays to ATR and free opsin apoprotein by 
hydrolysis of the Schiff base (SB) linkage. Although the conformational intermediates of 
photoactivated opsins are characterized, our knowledge of the apoprotein conformations existing 




































































Most of our understanding of the specific features of chromophore regeneration and activation 
mechanisms of cone visual pigments, and the cone opsin photocycle, has been extrapolated from 
comparison with previous rhodopsin studies. However, in order to unravel the specific details of 
chromophore regeneration and activation mechanisms of cone visual pigments, we need to 
integrate cone opsin photocycle findings with the wealth of rhodopsin studies. For instance, we 
know that the Meta II active photointermediate in cone opsins is short lived compared with that 
of rhodopsin [17-19]. Therefore, identifying the key structural features underlying retinal uptake 
and cone opsin activation mechanisms is clearly needed to fully understand visual perception at 
different light intensities and to develop novel therapeutic strategies to treat congenital retinal 
disorders. This knowledge should contribute, in addition, to broaden our knowledge on the 
structural information niche and the associated molecular mechanisms of the GPCR repertoire. 
In this review, we compile and discuss the recent advancements in the understandings of ligand 
binding (including allosteric modulation), stability, and chromophore regeneration of human 
cone visual pigments.  
Transient Cone Opsin Conformations prior to Chromophore Regeneration 
GPCRs are dynamic proteins that exhibit multiple functionally distinct conformational states [7]. 
Such a conformational ensemble provides GPCRs, like opsins, with a particular functional cycle 
comprising multiple steps (see Fig 1B). In the inactive dark-adapted state of rod and cone opsins, 
the retinal chromophore covalently binds to these visual pigments through its aldehyde group via 
a PSB linkage to the ε-amino group of Lys7.43 (numbering refers to the general scheme for 
GPCRs [20]). The PSB is then stabilized by a salt bridge with the carboxylic group of the 
counterion, Glu3.28 [17]. The active Meta II conformation formed upon pigment illumination 
decays with time yielding the empty opsin ready for free 11CR uptake thus restoring the dark-
adapted state during the adaptation mechanism of the visual cycle. The fate of a desensitized 
receptor -the conformational state of the receptor that has lost its activation ability and that 
eventually dissociates into free opsin and ATR- (Fig. 1B) includes either (i) receptor turn-over 
(i.e., regeneration of the apoprotein by chromophore reuptake), or (ii) deactivation (i.e., receptor 
phosphorylation and subsequent internalization). Therefore, the fast Meta II decay process, in 




































































photoactivated visual pigment) for a continuous visual photocycle ensuring an optimal function 
of the transduction cascade.  
11CR uptake and ATR exit mechanisms are both sensitive to conformational selection and 
existing equilibria among cone opsin intermediates. The Hofmann group proposed the retinal 
channeling hypothesis to describe the passage and exit of retinal into and out of the protein via 
specific entry/exit pathways [21]. Further studies suggested that this channel could involve two 
openings between transmembrane helices (TMs) 1 and 7, and between TMs 5 and 6 (Fig. 3A) 
[22, 23]. Interestingly, retinal isomers strictly bind to a specific subset of receptor conformations, 
namely 11CR and ATR can only bind inactive and active opsin conformations, respectively [24].  
In our recent studies on cone opsins, we showed that chromophore regeneration also involves 
dynamic conformations of the apoprotein [25-27]. Key differences with rhodopsin are that cone 
opsins: i) are more prone to spontaneous dissociation into free opsin and ATR, ii) exhibit a faster 
Meta II decay, and iii) have more serine and threonine residues in the C-terminus that can 
become phosphorylated [28].  
In an earlier study, we compared the regeneration process of rhodopsin and red cone opsin using 
retinal analogs added after the time taken for the apparent complete decay of the Meta II 
conformation. We found that while both 11CR and 9-cis-retinal (9CR) could regenerate red cone 
opsin, only 9CR was able to regenerate rhodopsin after the same time. This evidence suggests 
that these two opsin subtypes have different conformational dynamics, namely red cone opsin 
shows higher conformational flexibility than rhodopsin [25]. Similarly, a transient activation 
model, in which the transient intermediate conformation of ligand-free opsin potentiates the 
selective interaction between 11CR and ATR, has been proposed for rhodopsin as well [24]. 
Therefore, such transient opsin conformations may favor stable complexes with specific retinal 
isomers and this may play a role in cellular rhodopsin homeostasis.  
In a later study, we compared red versus green cone opsin regeneration by adding the retinal 
immediately after illumination. Intriguingly, these two highly homologous opsins displayed 
different regeneration modes likely due to different conformational dynamics prior to ligand 
binding. Another significant difference was that while photoactivated green cone opsin primarily 
formed an unprotonated SB linkage with endogenously added 11CR, red cone opsin showed the 




































































a recent study shows how an 11-cis-6-membered ring locked retinal analog can regenerate 
rhodopsin but not green cone opsin, hence suggesting that green cone opsins have a tighter 
retinal binding site [29]. On the other hand, blue cone opsin appeared to behave in a similar way 
to red cone opsin in response to canonical 11CR binding [27]. Thus, further studies are required 
to unveil the physiological significance of the initial unprotonated SB linkage formation and its 
conversion to 11CR-PSB green opsin in the visual transduction process of green cone opsin.  
Evolution has presumably favored a retinal isomeric configuration for coupling to a specific 
transient conformation of the ligand-free receptor. We may exploit this recognition to identify 
these conformations and attempt to characterize the process of retinal binding to opsin. 11CR is 
conserved throughout evolution because of the high quantum yield of its isomerisation reaction 
into ATR, as well as its fast response to the light stimulus that makes it one of the fastest 
reactions in nature [30]. In order to elucidate the regeneration mechanism of opsins, other retinal 
analogs such as 7CR, 9CR, 13CR, and ATR, have been used to study their binding properties to 
different visual pigments [31-33]. According to one of these studies, the estimated rank order of 
the binding energy for different retinal isomers has been found to be as follows: 9-cis > 13-cis > 
11-cis > all-trans [34]. 9CR is often used as an exogenous analog to study the structure and 
function of visual pigments [35]. Of note, while the binding free energy required by 9CR is 
lower than that of 11CR [34], the photoisomerization of isorhodopsin (9CR-bound opsin) is 
three times slower than that of rhodopsin (11CR-bound opsin) [36]. These conformational 
differences are in line with the observed behavior between rhodopsin and red and green cone 
opsin regenerated with 9CR and 11CR [26, 29].   
Overall, these recent findings confirm that opsin regeneration requires the photoactivated ligand-
free protein to adopt specific transient conformations. These conformations are distinct for each 
cone opsin and point to the existence of specific different regeneration pathways. Moreover, in 
accordance with the general lock-and-key hypothesis of protein-ligand interactions, retinal and 
retinal analogs seem to entail a combination of accessibility and specificity factors towards a 
given opsin conformation. Differences in the visual pigment molecular evolution and in 
associated intragenic epistatic interactions among these structurally similar red, green, and blue 
cone opsin pigments, may justify the different functionally-relevant conformations observed 




































































Opsin Stability and the Chromophore Regeneration Process 
One important issue in the study of visual pigments is the stability of purified opsins in 
detergent-containing solutions. Just like any other membrane protein, detergents compromise 
opsin stability when compared with native membrane environments, an effect that is boosted by 
the absence of ligand making the crystallization of ligand-free GPCRs, like opsin, a very 
challenging task. In the particular case of opsin, such instability eventually hampers its 
regeneration capacity under usual experimental conditions [39]. In rhodopsin, removal of 
palmitoyl anchors at C-terminal cysteines Cys3228.59 and Cys3238.60 have a strong inhibitory 
effect on opsin stability [40]. Previous studies in cone opsins closely related to the human blue, 
red, and green opsins revealed that these receptors lack palmitoylation [41]. Conversely, 
different opsin crystal structures have demonstrated that certain detergents can access the 
orthosteric binding site stabilizing the active state of this protein (Fig. 3B) [42-44]. Similarly, a 
recent study demonstrated that membrane cholesterol can bind at the same position in the 
adenosine A2A receptor (see Fig. 3B) [45]. This is noteworthy, because the authors performed 
tunnel calculations to show that the pathway followed by cholesterol to access the receptor is 
almost identical to the one suggested for retinal entry/exit into/from opsin. It is becoming more 
and more apparent that both detergents and membrane lipids play a key role in modulating opsin 
conformational stability and hence chromophore regeneration. In this regard, the effect of the 
lipid environment on the energetics of chromophore binding, in the case of rhodopsin, has been 
recently examined [46].  
As we have previously shown [25], 11CR could not regenerate photoactivated rhodopsin after 90 
min of photoactivation, whereas the 9CR analog could do so under the same experimental 
conditions. This finding challenged the long-held notion of the instability of ligand-free 
rhodopsin. More interestingly, both retinal analogs added a long time after photoactivation in 
solution could regenerate cone opsins more effectively than they did for rhodopsin, despite the 
former are be less stable in detergent [25] which is evident from the fact that rhodopsin has been 
found to be ~300 times more thermally stable at 37°C than cone opsins [47]. All in all, there is 
compelling evidence that there are different opsin stabilities in solution across the opsin 




































































biology such as retinal uptake and release that can be relevant factors in the pathophysiology of 
retinal degenerative diseases. 
Secondary Retinal Binding Site in Cone Visual Pigments 
As an alternative to the orthosteric site, the topography of GPCRs offers different binding 
pockets, where certain allosteric ligands can bind to modulate the response of the orthosteric 
ligand [48-50]. Some of these allosteric sites exist along the canonical binding pathway and 
transiently accommodate the ligand before reaching the orthosteric site [51, 52]. This also 
includes ligands that enter through the membrane [53, 54], such as retinal. Therefore, such sites 
may also exist along the binding pathway of retinal into opsins. In fact, binding of more than one 
retinal per opsin was proposed for rhodopsin already 15 years ago [55]. In this study, the authors 
suggested that a second retinal molecule could interact non-covalently with opsin at two possible 
sites they named entrance and exit sites [55]. Even before that, non-covalently bound retinal was 
reported in cone photoreceptors isolated from salamander retinas [56] and also in bovine 
rhodopsin from rod outer segment (ROS) disc membranes [57]. Later, X-ray crystallography 
revealed binding of one β-ionone (the ring moiety of the retinal molecule) at the extracellular 
side of TM7 [58]. X-ray crystallography has also proven that detergent molecules can bind in a 
cavity between TMs 1 and 7 [59], or even near the orthosteric site [60] (Fig. 3C). All these 
evidences support the proposal that retinoid molecules can bind to opsins at sites other than their 
canonical chromophore binding site. By the time of editing this review, recent structures of 
prostaglandin receptors have revealed that the orthosteric pocket in these receptors locates 
between TMs 1, 2 and 7, with one antagonist occupying the interface with the lipid interface in a 
very similar cavity than the one proposed as secondary binding site of retinal [61]. The possible 
existence of a secondary retinal binding site remained elusive in the case of the human cone 
visual pigments. Very recently, our regeneration experiments with photoactivated ligand-free 
cone opsins revealed the existence of such a site, which we suggested would be located between 
TMs 1 and 7, based on molecular docking (Fig. 3D) [26, 27]. In fact, our predictions positioned 
the second retinal molecule in a very similar location to that of a detergent molecule recently 
resolved in rhodopsin (Fig. 3D). In these studies, the proposed ligand binding mechanism 
involved a two-step mechanism: (i) 11CR binds to a transient opsin conformation at the 




































































incidentally displacing ATR out of the orthosteric binding site; and (ii) the secondary binding 
site accommodates additional 11CR, this time with slower kinetics. This second slower step 
would be due to the conformational change induced in the regenerated protein and the reduced 
availability of bulk 11CR, which would synergistically slow-down 11CR binding to the 
secondary site [26, 27]. While this secondary binding is not detected in the regeneration of 
red/green cone pigments by 9CR, this isomer can regenerate blue cone opsin via this mechanism. 
Such isomer selectivity suggests that the secondary retinal uptake event is not only due to free 
retinal availability but rather points to specific retinal-opsin interactions in different opsin 
conformational states. 
Ligand Binding of Visual Pigments and Congenital Retinal Disorders 
As discussed earlier, trichromatic color vision requires the absorption of photons from different 
visible wavelengths. The functional loss of any one of the cone pigments due to certain 
congenital disorders limits vision to dichromacy and the loss of two cone pigments leads to 
monochromacy [62]. Clinically identified opsin mutations result in retinal disorders ranging 
from a mild phenotype such as color blindness to a severe condition such as that found in cone 
dystrophies. The retinoid cycle (i.e., synthesis of 11CR from ATR) involves various retinoid 
binding proteins including transporter proteins and isomerizing enzymes [63]. Therefore, 
mutations in these proteins other than visual pigments can lead to vision impairment and is 
associated with several retinal diseases such as Leber congenital amaurosis (LCA), Stargardt 
macular degeneration, congenital cone-rod dystrophy, and retinitis pigmentosa (RP) [64].  
Altogether these deleterious mutations would restructure the functional conformation of the 
proteins which would further result in either compromised stability or ineffective retinoid 
binding. When the retinal binding event is compromised by point mutations that alter opsin 
stability, introducing an engineered disulfide bond into an opsin model improves the free-state 
opsin stability [65]. Although this approach is far from a practical implementation as a potential 
therapeutic strategy, it can be used to study the molecular features of mutant opsins. Opsins 
reconstituted into lipids [66], or supported by nanodiscs [67], can also be used to study the 
altered structure–function relationships of the visual pigments. In a therapeutic context, 
application of chemical chaperones can also counteract the mutation effect by recovering stable 




































































retinal analogs is a promising strategy with potential therapeutic impact as it is aimed at 
ameliorating the disrupted specific retinal–protein interactions in individuals with congenital 
disorders.  
Increasing experimental evidence supports the exogenous supplementation of retinal analogs in 
order to recover degenerative cone photoreceptor cells. In this regard, 9CR administration 
recovers cone function and improves cone density [69, 70], and administration of 9-cis-retinyl-
acetate increases the rhodopsin regeneration ratio, and dark adaptation in Rpe65 (an enzyme that 
acts on ATR) deficient mice [71]. The inherently less stable classical P23H rhodopsin mutant 
could also be regenerated with 9CR [72]. In other cases, blocking of constitutively active mutant 
visual pigments can be achieved by locked retinal isomers, that is, retinal analogs which are 
protected from photoisomerization, such as 11-cis-6mr-retinal [29, 73].  
LCA is a group of retinal degenerative disorders, in which vision loss is associated with 
perturbed 11CR synthesis but featuring relatively well-preserved retinal cells [74]. QLT, a 9-cis-
retinoid analog has been tested as a potential therapeutic agent for the treatment of the LCA 
clinical phenotype [75]. Our recent findings, with the 9CR isomer, showed improved 
regeneration at various time-points after photoactivation in the case of red, green, and blue cone 
pigments as well as in the case of rhodopsin [25-27]. Overall, these results provide novel 
evidence for the great potential of specific retinal isomers (alone or in combination with other 
molecules [76] that can act as allosteric modulators), or chemically modified retinoid analogs, as 
therapeutic tools for the successful treatment of visual disorders associated with mutations in 
cone photoreceptor proteins.  
Concluding Remarks and Future Perspectives 
Recent studies on ligand binding mechanisms of cone visual pigments stress the importance of 
specific conformational changes prior to visual pigment regeneration with 11CR, and the 
potential role of secondary retinal binding to the protein. The transient cone opsin 
conformational intermediates discussed here would serve as distinct fine-tuning molecular 
components modulating receptor activation and retinal release, and diverting the receptor from 
arrestin-mediated internalization. This effect may show similarities with ligand-biased signaling 
proposed for other GPCRs of pharmacological importance. Further studies on the kinetics and 




































































environments, would help unravel the structural basis of the visual photocycle and ligand binding 
mechanisms. The secondary retinoid binding to cone visual pigments may function as a 
regulatory mechanism of dark adaptation in the phototransduction process.  However, one of the 
fundamental questions (see Outstanding questions) is that the physiological role of this 
secondary retinal binding site has to be pondered and the involvement of the analyzed 
conformations in the development of retinal degenerative diseases deserves further investigation. 
The use of retinoid derivatives as potential agents to counteract the conformational defects of 
disease-causing opsin mutations deserves further investigation.  In this regard, the combined use 
of retinoids and other small molecules appears as a novel strategy for therapeutic intervention.  
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Allostery; the effect conferred by the binding of a ligand to a protein site other than the 
canonical (orthosteric) site, resulting in modulation of the function triggered by the orthosteric 
ligand. 
Chromophore; the molecule responsible for light absorption.  
Mono/Dichromacy; a color vision disorder in which only one/two among the three types of cone 
cells are functional resulting in altered color visual perception.  
Opsin cycle; in the presence of light, the opsin covalently-bound 11-cis-retinal isomerizes to all-
trans-retinal and triggers protein conformational changes leading to the active state, through a 
series of photointermediates. The visual pigment eventually loses all-trans-retinal and further 
regenerates with a new 11-cis-retinal molecule regenerating again retinal-bound opsin available 
for the next visual photo-transduction cascade (see Fig. 1). 
Opsins; heptahelical transmembrane class-A G protein-coupled receptors localized in membrane 
invaginations of photoreceptor cells in the retina. 
Palmitoylation; covalent addition of a palmitoyl group to specific Cys322 and Cys323 residues 
in rhodopsin (S-palmitoylation) known to improve opsin stability. 
Photoisomerization; the catalytic process by which incident light photons, of a specific 
wavelength, isomerize the opsin chromophore.  
Regeneration; the covalent binding of retinal to opsins by Schiff base formation with a Lys7.43 
residue at the orthosteric site.  
Retinal channeling hypothesis; the retinal molecule passes through a specific groove of the 
apoprotein to form retinal-bound visual pigment. It proposes specific entrance/exit sites for 11-
cis-/all-trans-retinal into opsins. 
Spectral tuning; the phenomenon of molecular variance around the protein bound chromophore 





































































Visual pigments; opsins, with their covalently bound chromophore, which are at their dark state 

























































































Figure 1: Photoactivation of Visual Pigments. (A) 11CR is covalently bound to a Lys residue 
of opsin, apoprotein of visual pigments, at their canonical chromophore binding site via a PSB 
linkage. The protonation is stabilized by a Glu residue which is known as the “counterion”. 
Photoactivation (hν) activates the visual pigments by isomerizing 11CR to ATR to form the 
Meta II state. Further release of ATR empties the retinal binding site leaving free opsin ready for 
regeneration. (B) The dark-state visual pigment (opsin bound with 11CR) gets activated by light 
(hν) and the 11CR isomerizes to ATR in fs, initially with unaffected protonation of the SB. After 
a series of short-lived photointermediates, the Meta I intermediate is formed that still harbours a 
PSB. Meta I conformation is converted, in the ms time range, to the Meta II active conformation, 
where the SB becomes deprotonated, the retinal linkage is eventually hydrolyzed, and the 
isomerized ATR is released from the opsin binding pocket. Free opsin can become 
phosphorylated, and processed for arrestin-mediated internalization, or it can be regenerated with 
a fresh 11CR molecule through a dynamic transient conformational state. (hν, quantum of light; 
fs, femtosecond; Meta I, metarhodopsin I; ms, millisecond; Meta II, Metharhodopsin II; 11CR, 
11-cis-retinal; ATR, all-trans-retinal).
Figure 2: Phylogenetic Tree and Sequence Alignment of Visual Pigments. (A) Phylogenetic 
tree of visual pigments of human, mouse, chicken, salamander, and goldfish constructed using 
the UPGMA method in MEGA [77]; (*) despite their names, these proteins have been 
considered to be red opsins [78, 79]. (B) Multiple sequence alignment of human rhodopsin (Rh), 
blue (B), green (G), and red (R) cone opsins computed using ClustalO [80]. Boxes with dashed 
lines indicate the reference residue for each helix (.50 according to Ballesteros and Weinstein 
numbering scheme [21]); boxes with full lines indicate the position of Lys7.43 (the anchoring 
point for retinal) and the glutamic residues (E3.28 and EECL2) that act as counterions. 
Figure 3: Entrance/Exit Openings for the Orthosteric Retinal Pocket and the Possible 
Secondary Binding Site in Cone Opsins. (A) Superposition of the active G-protein bound 
rhodopsin complex (PDB id 6CMO; in different colors for each TM helix: 1: cyan, 2: yellow, 3: 
red, 4: gray, 5: green, 6: blue, 7: pale-red) and dark-state rhodopsin (PDB id 1GZM; in white). 
ATR and 11CR are shown as sticks and with a dotted surface in green and red, respectively. The 




































































molecules superposed at the retinal binding pocket. Shown with ball-and-sticks are two β-
octylglucosides and one β-nonylglucoside molecules from rhodopsin structures with PDB ids 
4PXF (magenta), 4J4Q (orange) and 4X1H (dark-cyan), respectively, and one cholesterol 
molecule from a representative snapshot of a simulation of the A2A receptor taken from reference 
[47]. ATR and 11CTR are shown in sticks as reference. (C) A non-retinal small molecule (S-
RS01) binding near the TM5/6 opening that, in addition, occupies the space of the β-ionone ring 
of both ATR and 11CR (PDB id 6FK6). (D) The putative secondary retinal binding pocket 
proposed in reference [26]. As a representative, one of the obtained docking poses that can 
coexist with ATR or 11CR is shown in orange. An octylglucoside molecule (in magenta) has 
been crystallized in a very similar location in one rhodopsin crystal structure (PDB id 6FK6). 
(PDB id, Protein Data Bank identification code consisting of four characters combining letters 
and numbers and specific for the structure of a given protein; ATR, all-trans-retinal: 11CR, 11-
cis-retinal; TM, transmembrane helix; G protein, guanine nucleotide-binding protein, named 









































































 What is the underpinning physiological relevance of the transient conformations in
photoactivated ligand-free cone opsins prior to chromophore regeneration?
 Considering the fate of ligand-free GPCRs susceptible to arrestin-mediated
internalization, is there a molecular mechanism protecting the inactive ligand-free
receptors from entering in the receptor down-regulation pathway?
 More specifically, do the fine-tuning conformational changes in cone opsins play a
significant role in receptor down-regulation?
 What is the correlation between kinetics of secondary retinal binding and release of
the photoisomerized retinal from the activated cone opsins?
 Can the novel conformations proposed, and/or their alterations by mutations in the
opsin genes, play a role in the pathophysiology of retinal disorders?
Outstanding Questions
Highlights 
 Recent reports on the ligand binding mechanisms of cone visual pigments identified
transient conformations with concerted dynamics prior to regeneration with 11-cis-
retinal.
 A secondary retinal binding site has been identified in cone visual pigments. The
retinal at this allosteric site could act as a buffer facilitating the maintenance of
ligand-bound species.
 The novel results support the view that the actual stability of opsins may be the result
of the combined effect of the conformational dynamics of the ligand-free opsins and
the potential regulatory effects of the second retinal binding.
 Retinal analogues, like 9-cis-retinal, have a clear differential effect on the
regeneration mechanism of cone opsins. The combination of retinal analogues with
other small molecules can be an interesting approach for the treatment of congenital
retinal disorders.
Highlights
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